According to a previous mouse model of GPR116 deletion under the control of the Ap2Cre promoter, it has been suggested that GPR116 deletion in the AT results in systemic insulin resistance and ectopic fat accumulation29. The gene discussed is ADGRF5; the disease is Insulin resistance.